01
Cell source
Patient-derived (autologous) vs donor-derived (allogeneic).
02
Manufacturing method
Activation, expansion approach, release testing, and documentation.
03
Treatment setting
Registered clinical trial vs hospital program.
04
Monitoring plan
Management of fever, hypotension, infection, and lab changes.